Fibrinolysis and thrombosis

Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):423-33. doi: 10.1053/beha.1999.0034.

Abstract

The fibrinolytic system generates plasmin, which dissolves fibrin in haemostatic plugs and in thrombi. It is often regarded simply as a secondary phenomenon responsive to the generation of thrombi but it is, rather, in dynamic balance with fibrin formation, such that abnormalities in either can lead to thrombosis. This chapter summarizes the fibrinolytic system and its regulation. It considers the components of the system in blood, both in plasma and in circulating cells, with emphasis on protease-inhibitor balance. It goes on to discuss local fibrinolytic potential in thrombi, both venous and arterial, and in the diseased vessel wall, presenting evidence that increased local inhibition of fibrinolysis by PAI-1, PAI-2 and alpha2-antiplasmin is intimately involved in thrombus stability and in the generation of fibrin-rich vessel wall lesions. Finally, it reviews the evidence that defective plasma fibrinolysis has a causal role in venous and arterial thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood Platelets / chemistry
  • Blood Platelets / enzymology
  • Blood Platelets / physiology
  • Fibrin / drug effects
  • Fibrin / metabolism
  • Fibrinolysin / drug effects
  • Fibrinolysin / metabolism
  • Fibrinolysin / pharmacology
  • Fibrinolysis / drug effects
  • Fibrinolysis / physiology*
  • Humans
  • Serine Proteinase Inhibitors / blood
  • Serine Proteinase Inhibitors / pharmacology
  • Thrombosis / etiology*
  • Thrombosis / physiopathology

Substances

  • Serine Proteinase Inhibitors
  • Fibrin
  • Fibrinolysin